Tho manipulators frequently attempt to play games with these crossovers (and have fooled me in the past, and may well fool me again), in the case of SYN, the MASSIVE POTENTIAL will likely bring in hedge funds/'tutes'/all types of investors at these prices.
Some funds rebalance near end of September (end-of-quarter window dressing). The may have sold (or been 'stop-lossed' outta) their shares of SYN.
They may be the 'newly' interested...due to all the positive news.
IF they are allowed by their regulations to buy at this level, they will likely do so, in MY opinion. Technicals are at the 'heatin' up fer a potential Golden Cross' juncture.
Science is superb.
Near term, intermediate term and long term look goooooooooooooooood/excllent/WOW !!! for 1.70 price tag.
Yes, some possibility of dilution at SOME point, but always the case with small biotech. Moreover, partnering of various sorts could be announced at any point.
SHORTS are the ones at risk from this point on.
ONLY my opinion. Do independent DD. Please don't listen to me or anyone else, tho do check out comments re science, financials, technicals, etc. to verify if correct (whether positive OR negative).
Hammerlike candle printing...also startin' to look good for near term reversal (days, not months, imo).
I use MENTAL stop loss only...after bad experience years ago...AND that stop loss is only for 'additional trading shares' that I PLAN to sell if a move goes the wrong way with strength.
I consider it a luxury to hold huge number of shares for the very long term and I salute those who are able to do so.
Our family has been struggling with medical challenges for decades (immediate and extended family), so we do not have the luxury of holding large quantities indefinitely. We need to keep cash on hand and prevent or minimize loss by frequent profit taking (when possible), with a goal of holding at least SOME shares of dozens of gems...as 'core' shares...for the very, very long term. I try to hold many, many, mamy more shares on potential gem stocks (like SYN) on heavy pullbacks than I do on spikes.
Even IF one sells 'trading shares' at TINY loss several times, one may still profit overall, especially if one occasionally adds/trades at a key juncture and takes some profit to help protect gains (and have cash to add lower, if shares trade lower, or to diversify into other gems...OR, in my case...to have some cash available if/when for family needs.).
Peace Patients Patience Prudence Perseverance
Profit for Good Causes
Long term inverstors, short term traders, swing traders, funds/institutions (including hedge funds), anyone with an ounce of DD and a smidgen of common sense is having this mental conversation:
"Dang BLAST, this thing is oversold and UNDERVALUED."
If they have done two or more ounces of DD and have a modicum of common sense, they are strategizing for NICE buys and have already started to accumulate (or re-accumulate, or add).
Hugely oversold and gittin' ready fer technical launch.
Holding very SMALL amount, thus far, but would like to own scads.
Upside volume and moneyflow are key at these levels.
Also note CRB daily and weekly charts, along with other commoties.
Fedspeak may bring more volatility to gold & silver, but it is NOT impossible the lows are in for GDXJ and the triple long JNUG...and for CDE with recent retest. Meanwhile, please respond to all those 'CDE going bk' posts and other negativity about the 'bottom not in' so I have time to load up for bounce trades, especially with NICE volume upside...could mean reversal...MIGHT....need to see eod.
NOT a rec. JUST an opinion.
Profit for Good Causes
Long term value. En plus, technicals have improved near term with a retest of lows (into 1.30's) and a rise to present 1.40's.
Peace Patients Patience Perseverance Agape~
En plus, re 'treating the CAUSE'....see thread on this message board:
NEWS about SYN-010 IRB-syndrome: treats the cause of IRB!
Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day
In the keynote presentation, Mark Pimentel, MD, Director of the GI Motility Program and Laboratory at Cedars-Sinai Medical Center and Chairman of Synthetic Biologics' C-IBS Clinical Advisory Board, described SYN-010 as belonging to the pharmaceutical class of statins, which have mainly been prescribed for managing cholesterol levels. SYN-010 is a proprietary modified release formulation of a classical statin that is optimal for reducing methane-production by certain microorganisms (Methanobrevibacter smithii) in the gut while avoiding systemic drug absorption. Methane produced by these organisms is perceived as the underlying cause of bloating, pain and constipation associated with C-IBS, and may contribute to the pathology of other diseases. SYN-010 is intended to treat the "core" cause of C-IBS, not just the symptoms.
Listen to cc. jmo
Personally NOT a fan of any statin, ordinarily, due to side effects, but SYN is not a one-trick pony.
En plus, need to observe safety and other factors.
Go ahead and be a seller or non-buyer, while SYN rises from 1.58 to 1.70's intraday after smack down...to current levels.
Dang, even the most shallow technical DAYTRADER woulda at least TRADED this one up today. AND the most superficial swing trader would take note of the 50ma/200ma crossover potential here. jmo
Paix Sagesse Agape~
Lover of biotech here and (endlessly) learner of technical analysis of markets.
Draw various trendliines for 'minute' (various minute, hourly charts), for daily and for weekly timeframes.
Personally see a retest of a trendline, with intraday (thus far) bounce to upside.
On the horizon: 50ma/200ma crossover (Golden Cross).
Long time advocate for SYN. Years n years n years, from dip well below a buck when moniker was 'AEN.'
I DO take partial profits on volatile biotechs (and precious metals, energies) from time to time, and DO look fer 'add' points.
Personally, would call 1.60's/1.70's 'add area' ... but it's JUST my opinion. I recommend NOT following anyone else's opinion (whether alleged guru-folk or message board bulls OR bears)
re science, technicals or financials, but learning to be as informed as possible in all areas.
So NOT a rec for any stock or entry. Just a comment re my OWN conclusions as of this time/date.
I trade for family needs. Background in sciences/humanities. NONE in business/econ, etc. tho learnin' 10 yrs as tho doing PhD, then post-doc. Female of da species...need to set aside 'motherly' sentiment for beloved biotechs for harsh realities: hedge fund manipulation, unexpected good/bad news, etc.
Peace Patients Patience Prudence Perseverance
Profit for Good Causes
Good luck to you, SirKim! NICE strong move for GLD SLV as well!
Peace Joy Agape~
HL not (yet) green, but is another beaten-down potential turnaround, not quite like CDE (has zinc/lead, silver), but both with HUGE potential IF metals turn to upside with strength. (Zinc already nice moves.)
an entry to CDE may be both near term and longer term worthwhile.
ALL my opinions regarding miners are contingent upon REVERSAL to upside of gold and silver. ALWAYS, for any shares I would hold. For bounce trades, I personally attempt to trade INTO bottoms by buying large amounts repeatedly and SELLING all or most INTO the rise as a stock is still falling, but I do not recommend that practice or even any particular stock to anyone.
ONLY rec is to do thorough and independent DD AND to include technical analysis in overall DD.
CDE needs huge reversal to upside to prosper from HIGH silver prices. My personal opiinion is that THAT reversal is likely over the longer term.
I like MANY miners at current prices, IF and ONLY IF reversal for gold & silver occurs and continues.
See SYN website for pipeline, conferences, clinical trials and results. Enormous long term potential, in my opinion.
HUGE volatility in small biotech and NOT A REC, in any case. (I try to remember to post 'not a rec' as often as possible, since I'm an advocate for each to come to his/her OWN CONCLUSIONS, NEVER being unduly influenced by the opinion of anyone else, even alleged guru-folk.) Small biotech is often manipulated upside/downside, imo, by hedge funds. At this point, SYN has pulled back to 1.80's/1.90's from a sharp rise to 2.70's. NEWS HAS BEEN SUPERB, but the stock has fallen back to test 50ma/200ma, for which the crossover is imminent. SYN has cash near term, but dilution for ANY biotech is always a concern eventually...hence, another reason for volatility.
Meanwhile, SYN has ONE' STRONG BUY' REC and THREE 'BUY' RECs.
Went green at open to 1.90's, depped to 1.70's, now 1.80's.
Have personally been an advocate of SYN since it was trading in .40's, .60'MUCH watershed stuff in pipeline. Listen to today's cc
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)PR Newswire(Fri, Sep 12)
Synthetic Biologics to Host Phase II Trimesta™ for Multiple Sclerosis Conference CallPR Newswire(Thu, Sep 11)
Synthetic Biologics to Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor DayPR Newswire(Wed, Sep 10)
End of quarter 'window dressing' coming up fer some funds/institutions. Some may be selling OR have already sold/been stopped out, and will rebuy beaten-down potential turnarounds and gems, as I do.
JUST my opinion. Do independent DD, going to clinical trials and remarks by MDs, researchers. I personally think many shareholders on both SYN and PRAN are brilliant re the science associated with them.
Again, ONLY my opinion, and NOT a rec.
Peace Patients Patience Prudence Perseverance Agape~
Thanks, SirEdmund. See my post re 'China may buy gold...' also.
Positive news from BOTH India and China has arrived.... key seasonal and technical timing.
Thanks for insights re HL also...zinc, lead, silver.
"The country hasn’t announced any changes to state gold reserves since
authorities in 2009 said holdings totaled 1,054.1 metric tons. While China
holds the world’s biggest foreign-exchange reserves, bullion accounts for 1.1
percent of the total, compared with about 70 percent for the U.S. and Germany,
the biggest gold holders, World Gold Council data show.
“It is clear that western central banks over time will be reducing their
reserves and China and other Asian countries will be increasing,” David Marsh,
managing director at the Official Monetary and Financial Institutions Forum,
said in a Sept. 11 interview in Beijing. “Gold will become more traded amongst
central banks in the next 30 years because there are colossal imbalances in
world gold holdings as a percentage of overall asset reserves.”
Central banks, net buyers of gold for 14 straight quarters, helped limit
bullion’s losses last year that were the most since 1981 and may increase
purchases to as much as 500 tons this year after adding 409 tons last year,
the London-based council said Aug. 14. The precious metal rose 3 percent this
year as geopolitical tensions boosted demand for a haven."
Agree with this statemen by SirShulman (knows):
"Agree that HL with its vast Zinc and lead production (1/3 of revenue) is much safer bet right now. But if silver rebounds CDE will rise much higher than HL. I just prefer to own both."
Profit for Good Causes